↓ Skip to main content

Dove Medical Press

Decitabine-containing G-CSF priming regimen overcomes resistance of primary mediastinal neoplasm from early T-cell precursors to conventional chemotherapy: a case report

Overview of attention for article published in OncoTargets and therapy, August 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
11 Mendeley
Title
Decitabine-containing G-CSF priming regimen overcomes resistance of primary mediastinal neoplasm from early T-cell precursors to conventional chemotherapy: a case report
Published in
OncoTargets and therapy, August 2019
DOI 10.2147/ott.s214905
Pubmed ID
Authors

Yuhuan Yang, Shuna Yao, Jiuyang Zhang, Zheng Yan, Junfeng Chu, Haiying Wang, Zhihua Yao, Fan Zhang, Qingxin Xia, Yanyan Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 18%
Student > Ph. D. Student 2 18%
Researcher 2 18%
Student > Master 2 18%
Other 1 9%
Other 0 0%
Unknown 2 18%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 27%
Unspecified 2 18%
Pharmacology, Toxicology and Pharmaceutical Science 1 9%
Earth and Planetary Sciences 1 9%
Medicine and Dentistry 1 9%
Other 1 9%
Unknown 2 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2019.
All research outputs
#15,749,194
of 25,385,509 outputs
Outputs from OncoTargets and therapy
#840
of 3,016 outputs
Outputs of similar age
#197,781
of 359,381 outputs
Outputs of similar age from OncoTargets and therapy
#25
of 135 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,381 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 135 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.